LatentView Analytics jumped about 14% after revealing a $3 million strategic investment in Healtheon AI, a provider of agentic-AI solutions for U.S. healthcare Revenue Cycle Management.

Healtheon AI’s platform uses role-based AI agents in a decentralised system to streamline healthcare finance workflows—eligibility checks, prior authorisation, coding, claims processing, and denial remediation—delivering real-time processing and promising labour-cost and denial leakage reductions.

LatentView will invest via SAFE notes to secure a cornerstone stake in Healtheon AI, which specializes in an Agentic-AI framework for RCM services.

The stock’s year-to-date performance has been negative and the company sports a sizable market cap, with broader markets in the period edging lower.

The report includes a standard disclaimer and notes LatentView’s status as a global data analytics company.

Regulatory disclosures show the deal is non-related party, promoters have no interest, no government approvals are needed, and there won’t be tranches in completion.

For the period in review, net profit rose to ₹51 crore from ₹43 crore year over year, with an adjusted EBITDA margin around 24% after excluding ₹5 crore in one-time costs.

Historical share performance context is provided to illustrate how LatentView has traded over time.

LatentView expanded its investor meeting schedule for March 2026 with multiple brokerages, in line with SEBI regulations.

Analysts at PL Capital maintain a Buy rating, noting AI-led growth potential across financial services, retail, and industrial verticals, with projected mid‑teens to high-teens growth and margins in the mid-20s for FY27.

Latent View reported a 19.7% year-over-year rise in net profit to ₹50.14 crore and a 22% revenue increase to ₹278 crore for Q3 FY26.

FY25 figures show revenue of ₹848 crore and net profit of ₹173 crore, with trailing twelve-month revenue above ₹1,004 crore and Q3 FY26 maintaining strong margins.